Information Provided By: 
Fly News Breaks for January 23, 2019
MTBC
Jan 23, 2019 | 07:07 EDT
H.C. Wainwright analyst Kevin Dede says Medical Transcription Billing is "woefully under-appreciated and worthy of an aggressive call to attention for small cap investors despite the currently volatile market environment." He thinks the stock has the potential to be one of the best performers in his coverage universe this year and reiterates a Buy rating on the name with a $6 price target.
News For MTBC From the Last 2 Days
There are no results for your query MTBC
